MYCN and neuroblastoma: We also show that both drugs reduce the levels of MycN protein and that wt-TP53 neuroblastoma cell lines activate p53 signaling and undergo apoptosis, whereas mut-TP53 cells undergo cell cycle arrest in the G2/M-phase.